OpenAI’s ChatGPT Health links medical records and wellness apps in a private, physician-validated space. What it means for patient agency, privacy, and clinical practice.
ChatGPT Health: A New Phase for Personalized AI-Powered Wellness Read More »
Explore how AI shortens drug discovery timelines, improves target selection and compound design, and what this means for new treatments and patient care.
How AI Is Speeding Drug Discovery: From Targets to Trials Read More »
A concise overview of how AI is transforming medical diagnostics — from imaging and pathology to predictive analytics — improving patient outcomes and clinical workflows.
AI’s Pivotal Role in Modern Medical Diagnostics Read More »
Servier and Insilico Medicine struck a multi-program AI oncology discovery collaboration worth up to $888M, including $32M upfront. A concise analysis of roles, strategy and realistic impact.
Servier and Insilico Sign $888M AI Oncology Discovery Deal Read More »
How AI scribes cut documentation time, what consent and data safeguards providers must follow, why clinician review of AI notes matters, and practical steps for safe adoption.
AI Scribes in Healthcare: Reducing Physician Burden While Protecting Patients Read More »
Major tech companies are shifting from simple health apps to AI-driven, personalized health ecosystems. Learn how platforms like Ant Afu and Baidu Health aim to become everyday health companions.
How Tech Giants Build AI-Powered Personalized Health Ecosystems Read More »
A concise update on how AI is improving diagnostic accuracy, speeding workflows in radiology and pathology, and what clinicians should watch next.
AI’s Precision: How Machine Intelligence Is Rewriting Medical Diagnostics Read More »
How AI is accelerating RNA drug discovery with data-driven models, deep learning, and interactive workflows, cutting costs and timelines for pharma and investors.
AI Propels RNA Drug Discovery: Faster, Smarter Development for Pharma Read More »
For AI founders and health system leaders: how to prove economic ROI for AI tools, reduce clinician burden, and win procurement approval.
The Economic Imperative for AI in Healthcare: Prove the ROI or Lose Adoption Read More »
Insilico Medicine plans a $1 billion China hub for AI drug discovery. Analysis of why China appeals, how AI speeds discovery, and the global implications for biotech.
Insilico Medicine’s $1 Billion Bet on China: What It Means for AI Drug Discovery Read More »
